Harvard Bioscience (HBIO) announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. DeNelsky will also serve on the Board’s Nominating and Governance Committee.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBIO:
- Harvard Bioscience Offers CFO $100K Retention Bonus
- Harvard Bioscience at Risk of Nasdaq Delisting: Implications for Investors and Business Stability
- Harvard Bioscience Reports Q2 2025 Financial Results
- Harvard Bioscience Surpasses Revenue Guidance Amid Challenges
- Harvard Bioscience Amends Credit Agreement with Lenders